Revolutionary Advances in Limb Preservation at Medcare Hospital Al Safa

Medcare Hospital Al Safa has made significant strides in patient care by becoming the first facility in Dubai to implement SPUR® Retrievable Scaffold Therapy. This cutting-edge technology is specifically designed for individuals suffering from severely narrowed or blocked arteries below the knee, a condition that can lead to critical complications, particularly for those with diabetes.

Enhancing Blood Flow and Healing

For patients facing advanced circulation issues, restoring blood flow to the foot is crucial to limb preservation. Narrowed or blocked arteries can impede wound healing, potentially leading to infections and severe tissue damage. In severe cases, these complications may necessitate amputation. SPUR® therapy provides a minimally invasive solution that not only opens up blocked vessels but also temporarily supports the artery during treatment. After the procedure, the device is completely removed, leaving no permanent implant behind. This innovative approach is especially beneficial for the small, often compromised arteries found below the knee, preserving future treatment options for the patient.

Addressing the Diabetes Epidemic

The need for advanced solutions in limb salvage is particularly pressing in the UAE, where diabetes is prevalent and poses significant risks for peripheral arterial disease and diabetic foot complications. The International Diabetes Federation reports an alarming age-standardized prevalence of approximately 20.7% among UAE adults aged 20 to 79. By introducing SPUR® therapy, Medcare Hospital Al Safa is providing patients with an important new treatment avenue to combat these life-altering conditions.

A Patient-Centric Approach to Treatment

Bilal Al Soweissi, the COO of Medcare Hospital Al Safa, remarked on the importance of this new treatment option. “SPUR® therapy gives patients with complex below-the-knee arterial disease access to advanced care here in Dubai,” he stated. The facility’s commitment to improving patient outcomes is further endorsed by Dr. Saher Arour, a Consultant Vascular Surgeon who performed the first procedure in Dubai. He noted the significant difference that restoring blood flow can make for patients with non-healing foot wounds, emphasizing the importance of comprehensive care that goes beyond one single treatment.

The first patient treated with this breakthrough therapy was a 71-year-old Emirati woman with severe tissue loss due to inadequate blood flow. After successfully reopening her narrowed artery and implementing SPUR® therapy, follow-up imaging showed markedly improved blood flow, allowing her wound to heal without significant complications.

Comprehensive Multidisciplinary Care

Medcare Hospital Al Safa’s approach to treatment involves a multidisciplinary team dedicated to addressing the complexities of diabetic foot wounds alongside vascular interventions. This strategy aims to not only heal wounds but also preserve limbs while preventing avoidable amputations. Such comprehensive care combines specialized expertise in vascular and endovascular treatments with essential aspects of diabetic management and wound care.

In summary, the introduction of SPUR® Retrievable Scaffold Therapy at Medcare Hospital Al Safa signifies a large step forward in the fight against limb loss due to advanced vascular issues. By providing patients with innovative treatment options tailored to their unique needs, Medcare is setting itself apart as a leader in integrated healthcare delivery in the UAE.